{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:43:52Z","timestamp":1785293032504,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":15,"publisher":"Springer US","isbn-type":[{"value":"9781071602935","type":"print"},{"value":"9781071602942","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0294-2_47","type":"book-chapter","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T16:02:50Z","timestamp":1585324970000},"page":"791-800","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["In Vitro Growth Inhibition Assays of Leishmania spp."],"prefix":"10.1007","author":[{"given":"Sarah","family":"Hendrickx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Caljon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,28]]},"reference":[{"issue":"10","key":"47_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000313","volume":"2","author":"C Bern","year":"2008","unstructured":"Bern C, Maguire JH, Alvar J (2008) Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis 2(10):e313","journal-title":"PLoS Negl Trop Dis"},{"issue":"7385","key":"47_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/bmj.326.7385.377","volume":"326","author":"CR Davies","year":"2003","unstructured":"Davies CR, Kaye P, Croft SL, Sundar S (2003) Leishmaniasis: new approaches to disease control. BMJ 326(7385):377\u2013382","journal-title":"BMJ"},{"issue":"4","key":"47_CR3","doi-asserted-by":"publisher","first-page":"pii: e00048-18","DOI":"10.1128\/CMR.00048-18","volume":"31","author":"F Alves","year":"2018","unstructured":"Alves F, Bilbe G, Blesson S, Goyal V, Monnerat S, Mowbray C, Muthoni Ouattara G, Pecoul B, Rijal S, Rode J, Solomos A, Strub-Wourgaft N, Wasunna M, Wells S, Zijlstra EE, Arana B, Alvar J (2018) Recent development of visceral Leishmaniasis treatments: successes, pitfalls, and perspectives. Clin Microbiol Rev 31(4):pii: e00048-18","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"47_CR4","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","volume":"17","author":"SL Croft","year":"2011","unstructured":"Croft SL, Olliaro P (2011) Leishmaniasis chemotherapy\u2014challenges and opportunities. Clin Microbiol Infect 17(10):1478\u20131483","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"47_CR5","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1046\/j.1365-3156.2001.00754.x","volume":"6","author":"SL Croft","year":"2001","unstructured":"Croft SL (2001) Monitoring drug resistance in leishmaniasis. Trop Med Int Health 6(11):899\u2013905","journal-title":"Trop Med Int Health"},{"issue":"11","key":"47_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","volume":"6","author":"S Sundar","year":"2001","unstructured":"Sundar S (2001) Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 6(11):849\u2013854","journal-title":"Trop Med Int Health"},{"issue":"11","key":"47_CR7","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/cid\/cit102","volume":"56","author":"S Rijal","year":"2013","unstructured":"Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo TP, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert M, Dujardin JC (2013) Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis 56(11):1530\u20131538","journal-title":"Clin Infect Dis"},{"issue":"4","key":"47_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.resmic.2004.01.001","volume":"155","author":"L Fumarola","year":"2004","unstructured":"Fumarola L, Spinelli R, Brandonisio O (2004) In vitro assays for evaluation of drug activity against Leishmania spp. Res Microbiol 155(4):224\u2013230. https:\/\/doi.org\/10.1016\/j.resmic.2004.01.001","journal-title":"Res Microbiol"},{"key":"47_CR9","first-page":"27","volume":"133","author":"S Gupta","year":"2011","unstructured":"Gupta S (2011) Visceral leishmaniasis: experimental models for drug discovery. Indian J Med Res 133:27\u201339","journal-title":"Indian J Med Res"},{"key":"47_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1017\/s0031182016002031","volume":"145","author":"S Hendrickx","year":"2016","unstructured":"Hendrickx S, Guerin PJ, Caljon G, Croft SL, Maes L (2016) Evaluating drug resistance in visceral leishmaniasis: the challenges. Parasitology 145:453\u2013463. https:\/\/doi.org\/10.1017\/s0031182016002031","journal-title":"Parasitology"},{"key":"47_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/978-3-7091-1125-3_19","volume-title":"Drug resistance in Leishmania parasites","author":"L Maes","year":"2013","unstructured":"Maes L, Cos P, Croft S (2013) The relevance of susceptibility tests, breakpoints and markers. In: Ponte-Sucre A, Diaz E, Padr\u00f3n-Nieves M (eds) Drug resistance in Leishmania parasites. Springer, Vienna, pp 407\u2013429"},{"key":"47_CR12","volume-title":"Drug resistance in Leishmania parasites","author":"SML Hendrickx","year":"2018","unstructured":"Hendrickx SML, Croft SL, Caljon G (2018) The challenges of effective leishmaniasis treatment. In: Sucre AP (ed) Drug resistance in Leishmania parasites. Springer, Vienna"},{"issue":"11","key":"47_CR13","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1007\/s00436-018-6059-4","volume":"117","author":"M Van den Kerkhof","year":"2018","unstructured":"Van den Kerkhof M, Van Bockstal L, Gielis JF, Delputte P, Cos P, Maes L, Caljon G, Hendrickx S (2018) Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility. Parasitol Res 117(11):3601\u20133612","journal-title":"Parasitol Res"},{"issue":"12","key":"47_CR14","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1128\/AAC.00866-09","volume":"53","author":"RA Inocencio da Luz","year":"2009","unstructured":"Inocencio da Luz RA, Vermeersch M, Dujardin JC, Cos P, Maes L (2009) In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells. Antimicrob Agents Chemother 53(12):5197\u20135203","journal-title":"Antimicrob Agents Chemother"},{"key":"47_CR15","first-page":"76","volume-title":"Some physiological aspects and consequences of parasitism","author":"LS","year":"1955","unstructured":"LS (1955) Leishmaniasis in the hamster. In: Cole WH (ed) Some physiological aspects and consequences of parasitism. Rutgers University Press, New Brunswisck, NJ, pp 76\u201390"}],"container-title":["Methods in Molecular Biology","Trypanosomatids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0294-2_47","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T20:58:12Z","timestamp":1757710692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-0294-2_47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071602935","9781071602942"],"references-count":15,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0294-2_47","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"28 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}